Showing results (1681-1690 of 1,735) with videos related to
Sort By:
Pageof 174
CNS Spectrums|January 27, 2015
Ameliorating treatment-refractory depression with intranasal ketamine: potential NMDA receptor actions in the pain circuitry representing mental anguishLewis A Opler, Mark G A Opler, Amy F T ArnstenCNS Spectrums|August 14, 2012
High-dose desvenlafaxine in outpatients with major depressive disorderJames M Ferguson, Karen A Tourian, Gregory R RosasCNS Spectrums|August 14, 2012
An indirect comparison of the efficacy and safety of desvenlafaxine and venlafaxine using placebo as the common comparatorKristina A Coleman, Vanessa Y Xavier, Trish L Palmer, et al.CNS Spectrums|August 30, 2012
The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimagingTheodore A HendersonCNS Spectrums|July 14, 2012
Amygdalar volume in borderline personality disorder with and without comorbid post-traumatic stress disorder: a meta-analysisClaudia P de-Almeida, Amy Wenzel, Camila S de-Carvalho, et al.CNS Spectrums|July 14, 2012
Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatmentDavid Mischoulon, Stefania Lamon-Fava, Jacob Selhub, et al.CNS Spectrums|July 14, 2012
rTMS age-dependent response in treatment-resistant depressed subjects: a mini-reviewStefano Pallanti, Andrea Cantisani, Giacomo Grassi, et al.CNS Spectrums|February 27, 2015
Inpatient aggression in community hospitalsKatalin A Szabo, Christopher L White, Stephen E Cummings, et al.CNS Spectrums|July 29, 2022
Treatment response to esketamine nasal spray in patients with major depressive disorder and acute suicidal ideation or behavior without evidence of early response: a pooled post hoc analysis of ASPIREIbrahim Turkoz, Oliver Lopena, Giacomo Salvadore, et al.CNS Spectrums|March 16, 2023
Cognition in adults with borderline personality disorderIbrahim H Aslan, Jon E Grant, Samuel R ChamberlainPageof 174